Cargando…

Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases

We describe three cases of acute exacerbation of interstitial lung diseases (ILDs) in which patients were treated with pulsed-doses of corticosteroids followed by nintedanib and maintenance doses of corticosteroids. All cases responded well to pulsed-dose corticosteroids. However, in conventional pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakashima, Kazuki, Yanagihara, Toyoshi, Ishida, Sae, Ogo, Naruhiko, Egashira, Ayaka, Asoh, Tatsuma, Maeyama, Takashige
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974026/ https://www.ncbi.nlm.nih.gov/pubmed/33763326 http://dx.doi.org/10.1016/j.rmcr.2021.101385

Ejemplares similares

A Case of Drug-Induced Interstitial Lung Disease Caused by Epirubicin and Cyclophosphamide Therapy Before Breast Cancer Surgery
por: Egashira, Ayaka, et al.
Publicado: (2021)

Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
por: Yanagihara, Toyoshi, et al.
Publicado: (2020)

A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis
por: Nakashima, Kazuki, et al.
Publicado: (2021)

Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease
por: Ohgushi, Migiwa, et al.
Publicado: (2021)

A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin
por: Takatsuki, Kensaku, et al.
Publicado: (2021)

Successful treatment with mepolizumab for allergic bronchopulmonary mycosis complicated with bilateral septic arthritis of the knee joints caused by Methicillin-resistant Staphylococcus aureus
por: Yanagihara, Toyoshi, et al.
Publicado: (2020)

Pulmonary amyloidosis complicated with pulmonary hemosiderosis, diagnosed with bronchoscopy
por: Ogo, Naruhiko, et al.
Publicado: (2021)

Idiopathic Pulmonary Fibrosis Complicated by Adenocarcinoma and Organizing Pneumonia
por: Inutsuka, Yu, et al.
Publicado: (2022)

Early Recognition and Treatment of Relapsing Polychondritis
por: Yanagihara, Toyoshi, et al.
Publicado: (2022)

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum
por: Yanagihara, Toyoshi, et al.
Publicado: (2021)

A Refractory, Infected Lung Bulla and an Abscess Treated Using Percutaneous Drainage in a Patient With Human T-Lymphotropic Virus Type 1-Associated Myelopathy
por: Sugahara, Kaho, et al.
Publicado: (2021)

Tracheobronchial Chondritis Associated with Immune Checkpoint Blockade
por: Asoh, Tatsuma, et al.
Publicado: (2021)

Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases
por: Ito, Yoko, et al.
Publicado: (2019)

Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis
por: Ide, Maako, et al.
Publicado: (2018)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
por: Kato, Motoyasu, et al.
Publicado: (2023)

Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan
por: Urushiyama, Hirokazu, et al.
Publicado: (2022)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Nintedanib in children and adolescents with fibrosing interstitial lung diseases
por: Deterding, Robin, et al.
Publicado: (2023)

A case of welder's pneumoconiosis treated with corticosteroid followed by nintedanib
por: Kaida, Hideyuki, et al.
Publicado: (2022)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
por: Wollin, Lutz, et al.
Publicado: (2019)

Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
por: Cottin, Vincent, et al.
Publicado: (2021)

Effects of nintedanib by inclusion criteria for progression of interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022)

Correction to: Nintedanib: A Review in Fibrotic Interstitial Lung Diseases
por: Lamb, Yvette N.
Publicado: (2021)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Probucol attenuates hyperoxia-induced lung injury in mice
por: Kawaguchi, Tomonobu, et al.
Publicado: (2017)

A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib
por: Kakuwa, Tamaki, et al.
Publicado: (2018)

Depletion of club cells attenuates bleomycin-induced lung injury and fibrosis in mice
por: Yokoyama, Tetsuya, et al.
Publicado: (2017)

Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department
por: Jang, Hye Jin, et al.
Publicado: (2021)

Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
por: Schmid, Ulrike, et al.
Publicado: (2021)

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
por: Flaherty, Kevin R., et al.
Publicado: (2022)

Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe
por: Kaushal, Mohit, et al.
Publicado: (2022)

Interstitial pneumonia caused by dabigatran
por: Yanagihara, Toyoshi, et al.
Publicado: (2017)

Bax-inhibiting peptide attenuates bleomycin-induced lung injury in mice
por: Suzuki, Kunihiro, et al.
Publicado: (2017)

Early clinical experiences with nintedanib in three UK tertiary interstitial lung disease centres
por: Toellner, Hannah, et al.
Publicado: (2017)

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease
por: Vacchi, Caterina, et al.
Publicado: (2020)

Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
por: Westerink, Lotte, et al.
Publicado: (2022)

Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases
por: Bonella, Francesco, et al.
Publicado: (2022)

Comparing the efficacy and safety of two regimens of sequential systemic corticosteroids in the treatment of acute exacerbation of bronchial asthma
por: Aggarwal, Praveen, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2j7gd5aah86pka5644b7ulm2vp